ロード中...
Low‐dose desoxycorticosterone pivalate treatment of hypoadrenocorticism in dogs: A randomized controlled clinical trial
BACKGROUND: Desoxycorticosterone pivalate (DOCP) is a commonly used mineralocorticoid replacement for dogs with primary hypoadrenocorticism (HA), but manufacturer‐recommended dosing protocols can be cost‐prohibitive. Recent reports also have raised concerns that label dose protocols could be excessi...
保存先:
| 出版年: | J Vet Intern Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Inc.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8295656/ https://ncbi.nlm.nih.gov/pubmed/34114259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jvim.16195 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|